Competition Commission of South Africa v Mediclinic Southern Africa (Pty) Ltd and Another

Mediclinic Southern Africa sought to acquire control of Matlosana Medical Health Services, which owned two multidisciplinary private hospitals (Wilmed Park and Sunningdale) in Klerksdorp, North West Province. Mediclinic already owned a multidisciplinary hospital in nearby Potchefstroom. The Competition Tribunal found, on largely common-cause evidence, that the merger would lead to significant tariff increases at the target hospitals because they would move from National Health Network (NHN) tariffs to higher Mediclinic tariffs. This would adversely affect both insured and uninsured patients, particularly vulnerable uninsured patients who relied on lower-cost options. The Tribunal also found increased market concentration and dominance in the relevant geographic market, weakened bargaining power of medical schemes, deterioration in non-price competition, and insufficient merger-specific efficiencies. It therefore prohibited the merger. The Competition Appeal Court overturned the Tribunal’s decision, after which the Competition Commission sought leave to appeal to the Constitutional Court.

Leave to appeal was granted. The appeal was upheld. The order of the Competition Appeal Court was set aside, thereby restoring the Competition Tribunal’s prohibition of the merger. No order as to costs was made.

The case affirms the constitutional dimension of competition law in South Africa, particularly the requirement that merger control must account for access to healthcare and public interest considerations. It clarifies the limited circumstances in which appellate courts may interfere with findings of specialist competition tribunals. The judgment reinforces a transformative, rights-sensitive interpretation of the Competition Act aligned with the Constitution.